← FDA DRUG APPROVALS
FDA ANDA · ANDA204960
CISATRACURIUM BESYLATE PRESERVATIVE FREE
Sponsor: HENGRUI PHARMA
APPLICATION
ANDA204960
TYPE
ANDA
ORIGINAL APPROVAL
2017-01-27
LATEST ACTION
2023-02-06
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
CISATRACURIUM BESYLATE PRESERVATIVE FREEDiscontinued
CISATRACURIUM BESYLATE EQ 10MG BASE/ML · INJECTABLE · INJECTION
CISATRACURIUM BESYLATEDiscontinued
CISATRACURIUM BESYLATE EQ 2MG BASE/ML · INJECTABLE · INJECTION
CISATRACURIUM BESYLATE PRESERVATIVE FREEDiscontinued
CISATRACURIUM BESYLATE EQ 2MG BASE/ML · INJECTABLE · INJECTION
Approval history
2023-02-06Labeling · Supplement 15 · standardAP
2023-02-06Labeling · Supplement 16 · standardAP
2020-07-31Labeling · Supplement 8 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.